PMZ-2010 (Centhaquine) as a Resuscitative Agent for Hypovolemic Shock

PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

May 29, 2017

Primary Completion Date

September 19, 2018

Study Completion Date

October 21, 2018

Conditions
Hypovolemic ShockBlood Loss
Interventions
DRUG

Normal Saline

In addition to standard of care normal saline to be used as vehicle in the phase-II study to assess efficacy of PMZ-2010 as a resuscitative agent for hypovolemic shock

DRUG

Centhaquine

In addition to standard of care PMZ-2010 to be used as an experimental drug in the phase-II study to assess its efficacy as a resuscitative agent for hypovolemic shock

Trial Locations (7)

141001

Dayanand Medical College & Hospital, Ludhiana

160012

Post Graduate Institute of Medical Education and Research, Chandigarh

221005

ORIANA Hospital, Varanasi

440008

New Era Hospital & Research Institute, Nagpur

590010

KLE's Dr. Prabhakar Kore Hospital & Medical Research Centre, Belagavi

700020

Institute of Postgraduate Medical Education & Research and SSKM Hospital, Kolkata

Unknown

Seven Star Hospital, Nagpur

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pharmazz, Inc.

INDUSTRY

NCT04056065 - PMZ-2010 (Centhaquine) as a Resuscitative Agent for Hypovolemic Shock | Biotech Hunter | Biotech Hunter